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Abstract We investigated the involvement of NF-KB in the 
regulation of COX-2 protein expression and prostaglandin 
production in LPS-stimulated J774 macrophages. Incubation of 
J774 cells with LPS (1 (ig/ml) for 24 h caused an increase of 
COX-2 protein expression and accumulation of both PGE2 and 
6-keto-PGFia in the cell culture medium. Ammonium pyrrolid-
inedithiocarbamate (APDC, 0.1, 1, 10 (iM) and N-a-p-tosyl-L-
lysine chloromethylketone (TLCK, 1, 10, 100 ^M), two 
inhibitors of NF-KB activation, suppressed in a concentration-
dependent manner both LPS-induced COX-2 protein expression 
and prostanoid generation. Moreover, APDC and TLCK both 
inhibited the LPS-induced increase of NF-KB DNA binding 
activity and prevented IKB-CX degradation. Our results show for 
the first time that NF-KB is involved in COX-2 protein 
expression in LPS-stimulated J774 macrophages and suggest 
that inhibitors of NF-KB activation may represent a useful tool 
for the pharmacological control of inflammation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Cyclooxygenase, the enzyme which catalyzes the oxidation 
of arachidonic acid, is expressed in two isoforms, cyclooxy-
genase-1 (COX-1) and cyclooxygenase-2 (COX-2) [1]. COX-1 
is generally considered a constitutive enzyme and accounts for 
the release of prostaglandins (PGs) involved in the regulation 
of physiological functions [2]. After stimulation with lipopo-
lysaccharide (LPS) or some cytokines, many cell types, includ-
ing endothelial cells and macrophages, express the inducible 
isoform COX-2 which is responsible for the production of 
large amounts of proinflammatory PGs [3]. The promoter 
region of COX-2 genes in mice [4], rats [5], and humans [6] 
has been cloned and sequenced. This promoter region con-
tains a canonical TATA box and various putative transcrip-
tional regulatory elements such as CREB, AP2, SP1, GATA 
box, NF-IL6 and N F - K B . Amongst these elements, NF-IL6 
and N F - K B act as positive regulatory elements for the COX-2 
transcription in some cell lines [7]. N F - K B is an inducible 
transcription factor that mediates signal transduction between 
cytoplasm and nucleus in many cell types [8]. In resting cells, 
N F - K B is localized in the cytoplasm as a heterodimer com-
posed of two polypeptides of 50 kDa (p50) and 65 kDa (p65), 
which are non-covalently associated with cytoplasmic inhibi-
tory proteins, including IKB-OC. Upon stimulation by a variety 
of pathogenic inducers (such as viruses, mitogens, bacteria, 
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double-stranded RNA, agents providing oxidative stress and 
inflammatory cytokines), the N F - K B complex migrates into 
the nucleus and binds DNA recognition sites in the regulatory 
regions of the target genes [9]. Activation of N F - K B by LPS 
induces a cascade of events leading to the phosphorylation of 
IKB-CH and its further proteolytic degradation [10]. Recent 
observations suggest that the antioxidant ammonium pyrro-
lidinedithiocarbamate (APDC) and the serine protease inhib-
itor Ar-oc-/>-tosyl-L-lysine chloromethylketone (TLCK) are po-
tent inhibitors of N F - K B activation [10,11]. Despite the wealth 
of information derived from studies on COX-2 promoter 
gene, the potential regulatory role of N F - K B in COX-2 ex-
pression and prostaglandin production in inflammatory cells 
has not been investigated. Therefore, we have studied the 
effect of N F - K B inhibitors on COX-2 protein expression and 
prostaglandin production in LPS-stimulated J774 macro-
phages. 
2. Materials and methods 
2.1. Cell culture 
The murine monocyte/macrophage cell line J774 was cultured at 
37°C in humidified 5% C02/95% air in DMEM containing 10% fetal 
bovine serum, 2 mM glutamine, 100 IU/ml penicillin and 100 ug/ml 
streptomycin. The cells were plated in 24 culture wells at a density of 
2.5 X 10° cells/ml/well or 10 cm diameter culture dishes (1 X 107 cells/10 
ml/dish) and allowed to adhere for 2 h. Thereafter the medium was 
replaced with fresh medium and cells were activated with LPS (1 fig/ 
ml). APDC (0.1, 1, 10 uM) or TLCK (1, 10, 100 uM) was added to 
the cells 5 min before LPS challenge. In some experiments APDC (10 
uM) or TLCK (100 uM) was added 12 h after LPS challenge. Cell 
viability (>95%) was determined with the MTT assay [12]. 
2.2. Determination of prostaglandin production 
The accumulation of PGE2 and 6-keto-PGFln in the culture me-
dium was measured, without prior extraction or purification, by ra-
dioimmunoassay (RIA). The anti-PGE2 rabbit antibody showed the 
following cross-reactivity (%): PGEi 15, PGF2a 0.41, 6-keto-PGFla 
0.015, TXB2 < 0.0006. The relative cross-reaction (%) of the anti-6-
keto-PGFia rabbit antibody was: PGE2 0.4, PGF2a 1.12, PGD2 0.03, 
TXB2 < 0.009. 
2.3. Preparation of cytosolic fractions and nuclear extracts 
Extracts of macrophages stimulated for 2 h with LPS (1 ug/ml) in 
the presence or absence of APDC (0.1, 1, 10 uM) or TLCK (1, 10, 100 
uM) were prepared as described [13]. Briefly, harvested cells (2X107) 
were washed twice with ice-cold PBS and centrifuged at 180Xg for 10 
min at 4°C. The cell pellet was resuspended in 100 ul of ice-cold 
hypotonic lysis buifer (10 mM HEPES, 1.5 mM MgCl2, 10 mM 
KC1, 0.5 mM phenylmethylsulfonyl fluoride, 1.5 (ig/ml soybean tryp-
sin inhibitor, pepstatin A 7 ug/ml, leupeptin 5 ug/ml, 0.1 mM benza-
midine, 0.5 mM DTT) and incubated in ice for 15 min. The cells were 
lysed by rapid passage through a syringe needle five or six times and 
the cytoplasmic fraction was then obtained by centrifugation for 1 min 
at 13000Xg for 1 min. The nuclear pellet was resuspended in 60 ul of 
high salt extraction buffer (20 mM HEPES pH 7.9, 420 mM NaCl, 
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1.5 mM MgCl2, 0.2 mM EDTA, 25% v/v glycerol, 0.5 mM phenyl-
methylsulfonyl fluoride, 1.5 ug/ml soybean trypsin inhibitor, 7 ug/ml 
pepstatin A, 5 ug/ml leupeptin, 0.1 mM benzamidine, 0.5 mM DTT) 
and incubated with shaking at 4°C for 30 min. The nuclear extract 
was then centrifuged for 15 min at 13000Xg and supernatant was 
aliquoted and stored at —80°C. Protein concentration was determined 
with the Bio-Rad protein assay kit. 
2.4. Electrophoretic mobility shift assay (EMSA) 
Double-stranded oligonucleotides containing the N F - K B recogni-
tion sequence was end-labeled with [y-32P]ATP. Nuclear extracts (5 
ug) were incubated for 30 min with radiolabeled oligonucleotides 
(2.5-5.0X 104 cpm) in 20 u.1 reaction buffer containing 2 ug poly dl-
dC, 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM 
DTT, 1 ug/ml bovine serum albumin, 10% (v/v) glycerol. Nuclear 
protein-oligonucleotide complexes were resolved by electrophoresis 
on a 5%> non-denaturing polyacrylamide gel in 0.25 XTBE buffer at 
150 V for 2 h at 4°C. The gel was dried and autoradiographed with 
intensifying screen at —80°C for 20 h. 
2.5. Western blot analysis 
Immunoblotting analysis of COX-2 and IKB-CX proteins was per-
formed on J774 cells incubated with LPS (1 ug/ml) in the presence or 
absence of APDC or TLCK at different time points. Cytosolic frac-
tion proteins were mixed with gel loading buffer (50 mM Tris/10% 
SDS/10%i glycerol/10% 2-mercaptoethanol/2 mg bromophenol per ml) 
in a ratio of 1:1, boiled for 3 min and centrifuged at 10000Xg for 10 
min. Protein concentration was determined and equivalent amounts 
(75 ug) of each sample were electrophoresed in a 12% discontinuous 
polyacrylamide minigel. The proteins were transferred onto nitrocel-
lulose membranes, according to the manufacturer's instructions (Bio-
Rad). The membranes were saturated by incubation at 4°C overnight 
with 10% non-fat dry milk in PBS and then incubated with anti-lKB-a 
or anti-COX-2 antibodies (1:1000) for 1 h at room temperature. The 
membranes were washed three times with 1% Triton X-100 in PBS 
and then incubated with anti-rabbit immunoglobulins coupled to per-
oxidase (1:1000). The immune complexes were visualized by the ECL 
chemiluminescence method (Amersham). 
Fig. 2. Effect of APDC and TLCK on LPS-induced COX-2 protein 
expression. Western blot analysis shows the effect of APDC (10 
uM) and TLCK (100 uM) on COX-2 protein expression in J774 
macrophages stimulated with LPS (1 ug/ml) for 24 h. Basal level of 
COX-2 protein expression by unstimulated cells (lane 1). Induction 
of COX-2 protein expression by LPS-stimulated cells (lane 2). Inhib-
ition of LPS-induced COX-2 protein expression by APDC (0.1, 1, 
10 uM; lanes 3, 4 and 5) and TLCK (1, 10, 100 uM; lanes 6, 7 
and 8). The data illustrated are from a single experiment and are 
representative of a total of three separate experiments. 
2.6. Immunofluorescence of COX-2 
3174 macrophages were fixed in 3% formaldehyde for 5 min and 
subsequently permeabilized with 0.2% Triton X-100 for 10 min. Non-
specific binding sites were blocked by 10% FCS for 30 min. Samples 
were incubated with anti-COX-2 (1:200) antibody, followed by visual-
ization of IgG with a fluorescein-conjugated second antibody. The 
coverslips were mounted in 0.1 % p-phenylenediamine and 90% glyc-
erol solution in PBS and analyzed by fluorescence microscopy with a 
Zeiss Axiovert 100 microscope. 
2.7. Statistics 
Results were expressed as the mean±S.E.M. of n experiments. 
Statistical analysis was determined by Student's unpaired /-test with 
P<0 .05 considered significant. 
2.8. Reagents 
Phosphate buffer saline was from Celbio. DL-Dithiothreitol, phenyl-
methylsulfonyl fluoride, soybean trypsin inhibitor, pepstatin A, leu-
peptin and benzamidine were from Calbiochem. [y-32P]ATP and fluo-
rescein-conjugated second antibody were from Amersham. Poly dl-dC 
was from Boehringer-H. Anti-lKB-a was from Santa Cruz. Anti-
COX-2 antibody was a gift from G. Folco. Non-fat dry milk was 
from Bio-Rad. All other reagents were from Sigma. 
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Fig. 1. Effect of different concentrations of APDC and TLCK on 
PGE2 (A) and 6-keto-PGFia (B) production by J774 macrophages 
stimulated with LPS (1 ug/ml) for 24 h. APDC and TLCK were 
added to the cells at the same time as LPS. The values are ex-
pressed as means ± S.E.M. of four experiments performed in tripli-
cate. *P<0.05, **P<0.01 vs. control (LPS alone). 
3. Results 
3.1. Effect of APDC and TLCK on LPS-induced prostaglandin 
production and COX-2 expression 
Treatment of J774 macrophages with LPS (1 Ltg/ml) caused 
an accumulation of either PGE2 (20.62 ±1.4 ng/106 cells; 
« = 4) or 6-keto-PGFia (2.0 ±0.08 ng/10
6 cells; « = 4) as com-
pared to the release by unstimulated cells (1.09 ±0.1 ng/106 
cells and 0.22±0.09 ng/106 cells respectively; ra = 4). The ad-
dition of APDC (0.1, 1, 10 uM) to the cells 5 min before LPS 
challenge inhibited in a concentration-dependent manner the 
generation of both prostanoids. Thus, PGE2 production was 
reduced by 8.0 ±0.27%, 32 ±2.24%, 60 ±9.0% and 6-keto-
PGFi„ by 13 ±0.3%, 34 ±1.3%, 52 ±7.3%, respectively. Sim-
ilarly, TLCK (1, 10, 100 uM) was able to suppress the pro-
duction of PGE2 by 14 ± 3.78%, 35 ± 1.9% and 72 ± 10% and 
6-keto-PGF la by 27 ± 1.08%, 33 ± 0.5% and 63 ± 2.5%, respec-
tively (Fig. 1 A,B). Moreover, the stimulation of the cells with 
LPS (1 |ig/ml) resulted in an increase of COX-2 protein ex-
pression which was prevented by co-incubation with APDC or 
TLCK, as demonstrated by immunoblotting experiments (Fig. 
2). Addition of APDC (10 uM) or TLCK (100 uM) to the 
cells after 12 h LPS challenge did not significantly affect COX-
2 protein expression, PGE2 (18.4 ± 1.3% and 17 ± 1.3% respec-
tively; « = 3) and 6-keto-PGFia production (11 ±0.2% and 
22 ±0.12%) respectively; n-3), indicating that both agents 
did not cause direct inhibition of COX-2 activity (Fig. 
3A,B,C respectively). The MTT assay showed that none of 
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Fig. 3. Effect of delayed addition of APDC and TLCK on COX-2 
protein expression (A), PGE2 (B) and 6-keto-PGFia (C) production 
by J774 macrophages stimulated with LPS (1 ug/ml) for 24 h. 
APDC (10 uM) and TLCK (100 uM) were added to the cells at the 
same time as LPS (time 0) or 12 h after LPS challenge. A: Western 
blot analysis shows the effect of APDC and TLCK on COX-2 pro-
tein expression. The data illustrated are from a single experiment 
and are representative of a total of three separate experiments. B: 
Effect of APDC and TLCK on PGE2 production. The values are 
expressed as means ± S.E.M. of three experiments performed in trip-
licate. **P<0.01 vs. control (LPS alone). C: Effect of APDC and 
TLCK on 6-keto-PGFia production. The values are expressed as 
means ± S.E.M. of three experiments performed in triplicate. 
**i><0.01 vs. control (LPS alone). 
the tested compounds was cytotoxic at the concentrations 
used. 
3.2. COX-2 immunofluorescence 
Fig. 4 shows photographs of COX-2 immunofluorescence 
studies in J774 macrophages. Control cells showed only back-
ground staining, whereas cells stimulated with LPS (1 u.g/ml, 
for 24 h) revealed a diffuse accumulation of COX-2 protein in 
the cytoplasm. Treatment of cells with APDC (10 \\M) or 
TLCK (100 \iM) suppressed the appearance of COX-2 immu-
nostaining in the cytoplasm, confirming the results obtained 
with immunoblotting analysis. 
3.3. Effect of APDC and TLCK on NF-KB activation 
To detect N F - K B DNA binding activity, EMSA was per-
formed using nuclear extracts from LPS-stimulated J774 cells 
and a labeled oligonucleotide containing the N F - K B binding 
site. As shown in Fig. 5, while DNA-protein complexes were 
Fig. 4. Indirect immunofluorescence staining of COX-2 in J774 mac-
rophages. Background staining of unstimulated cells (a). Positive 
staining and diffuse cytoplasmic localization of COX-2 in cells 
stimulated with LPS (1 (ig/ml) (b). Disappearance of COX-2 immu-
nostaining in the cytoplasm of cells incubated with LPS (1 u,g/ml) in 
the presence of APDC (10 uM; c) and TLCK (100 uM; d). 
slightly detectable in nuclear extracts from control cells, a 
retarded band was clearly detected following stimulation of 
cells with LPS (1 ug/ml) evaluated at 2 h after LPS challenge. 
Incubation of cells with TLCK (1, 10, 100 uM) caused a 
concentration-dependent inhibition of LPS-stimulated N F -
KB binding. APDC (0.1, 1, 10 (J.M) also inhibited in a con-
centration-dependent manner LPS-stimulated N F - K B activa-
tion. The specificity of the retarded complex was demon-
strated by the fact that it was abrogated in the presence of 
a 100-fold molar excess of the same unlabelled oligonucleotide 
included in the reaction mixture. 
3.4. Effect of APDC and TLCK on IxB-a degradation 
The appearance of IKB-CX in the cytosolic fractions was in-
vestigated by immunoblotting analysis. A basal level of IKB-CX 
was detectable in the cytosolic fraction of unstimulated cells 
whereas, after challenge with LPS, IKB-CX was still present at 
5 and 15 min while it had disappeared at 30 and 45 min. 
APDC (10 uM) as well as TLCK (100 uM) prevented 
IKB-OC degradation, in fact the IKB-CX band remained un-
changed at both time points considered (Fig. 6). 
:B 
Fig. 5. Inhibition of NF-KB DNA binding by APDC and TLCK. 
The EMSA shows the effect of APDC or TLCK on LPS-induced 
NF-KB DNA binding in nuclear extracts from J774 macrophages. 
NF-KB DNA binding from unstimulated cells (lane 1). Increase of 
NF-KB DNA binding from cells stimulated with LPS (1 |Xg/ml) 
(lane 3). Inhibition of NF-KB DNA binding from cells stimulated 
with LPS (1 ug/ml) in the presence of TLCK (1, 10, 100 uM; lanes 
5, 7 and 9 respectively) or APDC (0.1, 1, 10 uM; lanes 11, 13 and 
15 respectively). Specificity of retarded complexes is demonstrated 
by the addition of an excess of the same unlabeled oligonucleotide 
used as probes (lanes 2, 4, 6, 8, 10 and 12). The data illustrated are 
from a single experiment and are representative of a total of three 
separate experiments. 
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Fig. 6. Effect of APDC and TLCK on LPS-induced degradation of 
iKB-a. Western blot analysis shows the effect of APDC (10 uM) 
and TLCK (100 uM) on degradation of IKB-CI in 1774 macrophages 
collected at 5, 15, 30 and 45 min after LPS (1 |ig/ml) challenge. 
Control: basal level of IKB-a band was present in the cytosolic frac-
tion of unstimulated cells. LPS: IKB-CH band has disappeared from 
the cytosolic fraction at 30 and 45 min. APDC and TLCK: IKB-CC 
band remained unchanged at all time points considered. The data il-
lustrated are from a single experiment and are representative of a 
total of three separate experiments. 
4. Discussion 
A growing body of evidence suggests that high levels of 
PGs, synthesized by COX-2, are involved in mediating both 
acute and chronic inflammation [1]. N F - K B was demonstrated 
to play a relevant role in the expression of many genes in-
volved in the inflammatory process [14]. The molecular signal-
ing mechanisms by which pathogenic stimuli induce COX-2 
expression and PG production by macrophages have not been 
investigated. Here, we report that two inhibitors of N F - K B 
activation, APDC and TLCK, reduced in a concentration-
related manner PGE2 and 6-keto-PGFia production by 
LPS-stimulated J774 macrophages. Inhibition of prostaglan-
din production by PDTC and TLCK was not dependent on 
direct inhibition of COX-2 activity since both compounds, 
when added to the cells 12 h after LPS challenge, did not 
affect the enzyme catalytic activity. Moreover, the reduction 
of PG production seems to be related to inhibition of COX-2 
gene expression, because both compounds reduced the level of 
COX-2 protein expression, as demonstrated by immunoblot-
ting and immunofluorescence experiments. Our results are in 
agreement with recently reported data demonstrating that 
PDTC inhibits IL-1-induced PGE2 production and COX-2 
protein expression in rat mesangial cells and inhibits COX-2 
protein expression at the post-transcriptional level without 
affecting COX-2 mRNA [15]. Previous observations indicated 
that N F - K B activation requires the liberation of free N F - K B in 
the cytoplasm, after which N F - K B migrates into the nucleus 
and binds to the appropriate DNA region to promote tran-
scription [8]. One of the most important intracellular events 
for N F - K B activation is the proteolytic cleavage of inhibitor 
proteins such as IKB-CC, which allows the liberation of free 
N F - K B [10]. Inhibition of this proteolytic pathway results in 
the inhibition of N F - K B activation. This study demonstrates 
that the serine protease inhibitor TLCK, which is known to 
block the degradation of IKB-OC and prevent the activation of 
N F - K B [10], inhibits PG production and COX-2 protein ex-
pression by interfering with N F - K B activation. Recent evi-
dence suggests that the activation of N F - K B may also be 
under the control of oxidant/antioxidant balance [16]. This 
hypothesis is mainly based on the observation that low doses 
of peroxides, including H2O2 and tert-butyl-hydroperoxide, 
induce N F - K B activation whereas some antioxidants prevent 
it [17,18]. Our results are in agreement with this hypothesis 
since it is conceivable that APDC inhibited N F - K B activation 
through an antioxidant mechanism. Moreover, the transient 
loss of IKB-a which occurs in LPS-stimulated J774 cells was 
prevented by either APDC and TLCK suggesting that these 
compounds inhibit N F - K B activation by stabilizing IKB-CC. 
Taken together, our results show that the antioxidant 
APDC and the serine proteinase inhibitor TLCK are able to 
reduce COX-2 protein expression and PG production by ac-
tivated macrophages and suggest an involvement of N F - K B in 
the induction of COX-2. However, since we have not inves-
tigated the effect of PDTC and TLCK on binding of N F - K B 
proteins to the COX-2 promoter, further studies on COX-2 
gene transcription will better clarify the mechanism by which 
N F - K B modulates COX-2 protein expression. This study sug-
gests that inhibitors of N F - K B activation may represent a 
useful tool for investigating the mechanisms which bring 
about the inflammatory process as well as potential agents 
for its pharmacological control. 
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